Note: The full article and accompanying features are only available whilst being signed in.
Summary
January 2012: the beginning of a new year, with new hopes and dreams. So where have we got to in Pharma, and what is on the agenda this year?
We all know that we are a sector in crisis, and that the traditional blockbuster business model of the past is unsustainable now. So, what should Big Pharma be doing? This article will examine what big Pharma are doing and where we believe they would be best placed to be doing something.
Want more?
The content of this page been summarized. To view the full content, please register or sign in to the Eularis web site.
Register with Eularis
or
Sign in